Targeting E3 ubiquitin ligases: Mechanistic breakthroughs and novel clinical translation pathways for tumor radioimmunotherapy.

Yang Q, Xing X, Wang Y, Wang X, Han Y, Ren J, Zhang Z, Tang J, Zhao J

Open source

DOI: 10.1186/s12943-026-02739-x
Published: 2026 Jul 22
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02739-x,
  title = {Targeting E3 ubiquitin ligases: Mechanistic breakthroughs and novel clinical translation pathways for tumor radioimmunotherapy.},
  author = {Yang Q and Xing X and Wang Y and Wang X and Han Y and Ren J and Zhang Z and Tang J and Zhao J},
  year = {2026},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-026-02739-x},
  url = {https://doi.org/10.1186/s12943-026-02739-x}
}

RIS

TY  - JOUR
TI  - Targeting E3 ubiquitin ligases: Mechanistic breakthroughs and novel clinical translation pathways for tumor radioimmunotherapy.
AU  - Yang Q
AU  - Xing X
AU  - Wang Y
AU  - Wang X
AU  - Han Y
AU  - Ren J
AU  - Zhang Z
AU  - Tang J
AU  - Zhao J
PY  - 2026
JO  - Molecular cancer
DO  - 10.1186/s12943-026-02739-x
UR  - https://doi.org/10.1186/s12943-026-02739-x
ER  -

APA

Q, Y., X, X., Y, W., X, W., Y, H., J, R., Z, Z., J, T., & J, Z. (2026). Targeting E3 ubiquitin ligases: Mechanistic breakthroughs and novel clinical translation pathways for tumor radioimmunotherapy.. Molecular cancer. https://doi.org/10.1186/s12943-026-02739-x

Source records

pubmed · retrieved 2026-09-25T21:24:57.598Z
europe-pmc · retrieved 2026-09-25T21:24:57.621Z
doaj · retrieved 2026-09-25T21:24:57.618Z